Divi's Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.
Divi's Laboratories Ltd., with Security Code 532488, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 23,030.00 | 5,380.00 | 23,820.00 | 20.25 | -3,730.00 | 790.00 | -950.00 | 7,130.00 |
2023-10-01 | 2023-12-31 | 18,080.00 | 3,580.00 | 19,020.00 | 13.50 | -3,480.00 | 940.00 | -950.00 | 4,900.00 |
2023-10-01 | 2023-12-31 | 18,550.00 | 3,580.00 | 19,500.00 | 13.50 | -3,690.00 | 950.00 | -950.00 | 4,890.00 |
2023-07-01 | 2023-09-30 | 18,680.00 | 3,420.00 | 19,530.00 | 12.89 | -3,340.00 | 850.00 | -940.00 | 4,640.00 |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 9% |
3 Years: | 4% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 4% |
3 Years: | -7% |
TTM: | -13% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 23% |
3 Years: | 0% |
1 Year: | 21% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 10% |
3 Years: | 4% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | 3% |
3 Years: | -7% |
TTM: | -12% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 23% |
3 Years: | 0% |
1 Year: | 21% |
Pharmaceutical firm Divi's Laboratories on Thursday said it has received approval from the US health regulator for its anti-anxiety drug, lorazepam tablets.
Drug firm Divi's Laboratories on Tuesday reported a 12 per cent increase in its consolidated net profit to Rs 866 crore for the quarter ended December 2022.
Pharmaceutical major Divi's Laboratories will invest Rs 1,500 crore in Telangana to set up a new manufacturing facility.